URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Karl Kieburtz

Concepts (462)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Parkinson Disease
50
1991
402
9.600
Why?
Huntington Disease
22
1994
124
5.630
Why?
Neuroprotective Agents
15
1996
125
3.740
Why?
Clinical Trials as Topic
21
1996
685
3.670
Why?
Antiparkinson Agents
16
1998
108
2.740
Why?
Levodopa
16
1991
111
2.400
Why?
Hot Flashes
3
2003
25
1.790
Why?
Movement Disorders
5
2002
51
1.740
Why?
Humans
127
1986
37165
1.710
Why?
Research Design
12
1996
340
1.680
Why?
AIDS Dementia Complex
12
1991
145
1.600
Why?
Middle Aged
67
1990
10013
1.560
Why?
Ubiquinone
8
1996
24
1.490
Why?
Monoamine Oxidase Inhibitors
5
2000
39
1.410
Why?
HIV Infections
12
1990
616
1.370
Why?
Research Subjects
4
2008
17
1.360
Why?
Female
80
1990
20222
1.350
Why?
Disease Progression
22
1994
533
1.290
Why?
Male
78
1990
20139
1.260
Why?
Severity of Illness Index
13
2000
943
1.250
Why?
Double-Blind Method
26
1996
996
1.240
Why?
Dementia
4
1990
104
1.230
Why?
Biomedical Research
2
2007
137
1.120
Why?
Cognition Disorders
9
1991
291
1.080
Why?
Neurology
3
1996
91
0.990
Why?
Neuropsychological Tests
22
1993
391
0.980
Why?
Postmenopause
3
2003
42
0.970
Why?
Acquired Immunodeficiency Syndrome
6
1989
201
0.950
Why?
Benzothiazoles
3
2004
52
0.940
Why?
Treatment Outcome
27
1993
2671
0.930
Why?
Outcome Assessment (Health Care)
5
2005
301
0.910
Why?
Brain
7
1990
1228
0.890
Why?
Aged
37
1990
7392
0.890
Why?
Parkinsonian Disorders
2
2000
28
0.880
Why?
Adult
47
1990
11572
0.850
Why?
Neurosurgery
1
2012
10
0.850
Why?
Cognition
8
1990
232
0.840
Why?
Homocysteine
2
2008
26
0.840
Why?
Antipsychotic Agents
2
2010
116
0.830
Why?
Evidence-Based Medicine
4
2002
210
0.820
Why?
Neurosurgical Procedures
5
2005
44
0.810
Why?
Attitude to Health
2
2006
228
0.810
Why?
Drug Therapy
1
2011
48
0.810
Why?
Gene Transfer Techniques
3
2006
154
0.800
Why?
Excitatory Amino Acid Antagonists
2
1999
40
0.780
Why?
Cyclohexanecarboxylic Acids
3
2003
46
0.770
Why?
Amines
3
2003
63
0.760
Why?
Dietary Supplements
2
2005
46
0.760
Why?
gamma-Aminobutyric Acid
3
2003
97
0.740
Why?
Selegiline
4
1994
67
0.740
Why?
Clinical Trials, Phase I as Topic
2
1991
11
0.720
Why?
Ophthalmology
1
2009
18
0.720
Why?
Dyskinesia, Drug-Induced
2
2008
14
0.720
Why?
Methionine
1
2009
49
0.710
Why?
tau Proteins
1
2011
105
0.710
Why?
Memory Disorders
2
2006
48
0.700
Why?
Decision Making
3
2006
227
0.700
Why?
Indoles
1
2010
104
0.690
Why?
Catechols
3
2000
11
0.690
Why?
Thiazolidinediones
1
2009
76
0.690
Why?
Dopamine Agonists
2
2006
29
0.680
Why?
Neurofilament Proteins
1
2008
27
0.670
Why?
Neurologic Examination
14
1991
146
0.670
Why?
Consent Forms
1
2008
4
0.670
Why?
Isoleucine
1
2008
11
0.670
Why?
Ethics Committees, Research
1
2008
17
0.660
Why?
Trust
1
2008
30
0.660
Why?
Valine
1
2008
32
0.650
Why?
Perception
1
2008
66
0.640
Why?
Calcium Channel Blockers
1
2008
69
0.630
Why?
Therapeutics
1
2007
6
0.610
Why?
Zidovudine
4
1991
71
0.580
Why?
Magnetic Resonance Imaging
8
1990
1019
0.580
Why?
Ethics, Research
2
2005
16
0.580
Why?
Third-Party Consent
1
2006
5
0.570
Why?
Proxy
1
2006
14
0.570
Why?
Drug Therapy, Combination
8
1992
397
0.560
Why?
Human Experimentation
1
2006
16
0.560
Why?
Advance Directives
1
2006
24
0.560
Why?
Mental Competency
1
2006
27
0.560
Why?
Drug Administration Schedule
5
1996
374
0.550
Why?
Rural Population
1
2006
75
0.550
Why?
Therapeutic Human Experimentation
1
2005
4
0.550
Why?
Catechol O-Methyltransferase
3
2000
5
0.550
Why?
Welding
1
2005
5
0.540
Why?
Manganese Poisoning
1
2005
11
0.530
Why?
Follow-Up Studies
18
1992
1889
0.530
Why?
Randomized Controlled Trials as Topic
8
2002
415
0.530
Why?
Uric Acid
3
2008
49
0.510
Why?
Informed Consent
4
2006
86
0.510
Why?
Cohort Studies
14
1996
984
0.500
Why?
Data Collection
1
2005
231
0.490
Why?
Quality of Life
6
2003
528
0.490
Why?
Time Factors
9
1993
3234
0.480
Why?
Dose-Response Relationship, Drug
9
1992
1142
0.480
Why?
Occupational Exposure
1
2005
114
0.470
Why?
Placebos
4
2000
185
0.460
Why?
Indans
4
2002
20
0.460
Why?
Biological Markers
11
1994
564
0.460
Why?
Practice Guidelines as Topic
1
2006
319
0.460
Why?
Physician's Practice Patterns
1
2006
268
0.450
Why?
Acetates
1
2003
65
0.440
Why?
Alzheimer Disease
1
2006
299
0.440
Why?
HIV-1
3
1995
593
0.430
Why?
Retrospective Studies
7
1991
2302
0.430
Why?
Interferon-beta
1
2002
63
0.420
Why?
Cerebrovascular Disorders
2
1992
114
0.420
Why?
Headache
2
1995
52
0.410
Why?
Antioxidants
5
2002
201
0.410
Why?
Multiple Sclerosis
1
2002
129
0.400
Why?
Acetamides
3
1996
32
0.390
Why?
Epilepsy, Temporal Lobe
2
2010
47
0.390
Why?
Pain
2
1998
392
0.390
Why?
Risk Assessment
4
2005
875
0.380
Why?
Dehydroepiandrosterone Sulfate
1
2000
7
0.380
Why?
Disease Models, Animal
3
2000
974
0.380
Why?
Translational Medical Research
2
2010
38
0.370
Why?
Benzophenones
1
2000
1
0.370
Why?
Autonomic Nervous System
1
2000
70
0.370
Why?
Vitamin E
2
1994
87
0.370
Why?
HIV Seropositivity
1
2000
36
0.360
Why?
Administration, Oral
5
2002
314
0.360
Why?
Peripheral Nervous System Diseases
3
1991
104
0.360
Why?
Mice, SCID
1
2000
171
0.350
Why?
Behavioral Symptoms
2
2006
15
0.350
Why?
Amitriptyline
1
1998
8
0.340
Why?
Adrenergic Uptake Inhibitors
1
1998
22
0.340
Why?
Mexiletine
1
1998
13
0.340
Why?
Viral Load
3
2000
141
0.340
Why?
Peer Review, Research
1
1998
24
0.340
Why?
Conflict of Interest
1
1998
37
0.330
Why?
RNA, Viral
3
2004
294
0.330
Why?
Nervous System Diseases
2
1991
148
0.330
Why?
Carbidopa
2
2004
18
0.320
Why?
Anti-Arrhythmia Agents
1
1998
82
0.320
Why?
Motor Activity
4
2000
186
0.320
Why?
Mental Status Schedule
3
1997
33
0.310
Why?
Analysis of Variance
7
1998
749
0.310
Why?
Nitriles
3
2000
39
0.310
Why?
China
3
2005
98
0.310
Why?
Placebo Effect
4
1999
36
0.300
Why?
Periodicals as Topic
1
1998
79
0.300
Why?
Cross-Sectional Studies
4
2005
676
0.290
Why?
Publishing
1
1997
45
0.290
Why?
Didanosine
2
1992
21
0.290
Why?
Health Maintenance Organizations
2
1986
30
0.280
Why?
Drug Utilization
2
1986
47
0.270
Why?
Sex Distribution
2
2005
161
0.270
Why?
Proportional Hazards Models
6
2001
426
0.270
Why?
Receptors, N-Methyl-D-Aspartate
2
1991
87
0.270
Why?
Coenzymes
5
1996
26
0.260
Why?
Longitudinal Studies
8
1998
413
0.260
Why?
Age Distribution
2
2005
227
0.260
Why?
Prevalence
3
2005
582
0.260
Why?
Antiretroviral Therapy, Highly Active
3
2002
66
0.260
Why?
Case-Control Studies
5
1996
624
0.250
Why?
Repetitive Sequences, Nucleic Acid
1
1994
79
0.250
Why?
Corpus Striatum
4
1996
152
0.240
Why?
Data Interpretation, Statistical
3
2005
157
0.240
Why?
CD4 Lymphocyte Count
6
1997
160
0.230
Why?
Muscular Diseases
1
1994
69
0.230
Why?
United States
4
1986
2847
0.230
Why?
Aged, 80 and over
5
2005
2588
0.230
Why?
Clinical Trials, Phase II as Topic
2
2006
14
0.220
Why?
Multicenter Studies as Topic
3
1996
127
0.220
Why?
Activities of Daily Living
5
1996
273
0.220
Why?
Trinucleotide Repeats
2
1999
40
0.220
Why?
United States Food and Drug Administration
2
2009
46
0.220
Why?
Anticonvulsants
2
2010
125
0.220
Why?
Nontherapeutic Human Experimentation
1
2012
5
0.220
Why?
Chickenpox
1
1992
23
0.220
Why?
Seizures
2
1990
155
0.220
Why?
Brain Diseases
2
1989
134
0.210
Why?
Dopamine
2
1991
197
0.210
Why?
AIDS-Related Complex
1
1992
14
0.210
Why?
Sex Factors
5
1995
613
0.210
Why?
Dopamine Agents
3
2005
31
0.210
Why?
Neurodegenerative Diseases
1
2012
44
0.210
Why?
Area Under Curve
2
2007
64
0.210
Why?
Dopamine Antagonists
1
2011
22
0.210
Why?
Movement
2
2009
168
0.200
Why?
Psychomotor Disorders
2
1997
20
0.200
Why?
Fatty Acids, Omega-3
1
2011
23
0.200
Why?
Vitamin B 12
1
1991
23
0.200
Why?
Heart Rate
2
2000
457
0.200
Why?
Vitamins
2
2007
34
0.200
Why?
Aneurysm, Dissecting
1
1991
19
0.200
Why?
Bipolar Disorder
1
1991
48
0.200
Why?
History, 21st Century
1
2011
48
0.200
Why?
Capacity Building
1
2010
4
0.200
Why?
Neurturin
1
2010
1
0.200
Why?
Academies and Institutes
1
2010
13
0.200
Why?
Polyneuropathies
2
2000
42
0.200
Why?
Caudate Nucleus
2
1996
22
0.190
Why?
Incidence
7
2001
682
0.190
Why?
Carbazoles
1
2010
29
0.190
Why?
Drug Design
1
2010
45
0.190
Why?
Carotid Artery Diseases
1
1991
62
0.190
Why?
Comorbidity
3
2005
377
0.190
Why?
Riluzole
1
2010
2
0.190
Why?
Temporal Lobe
1
2012
128
0.190
Why?
Endarterectomy
1
1990
13
0.190
Why?
Animals
7
1996
16416
0.180
Why?
Statistics, Nonparametric
2
1998
269
0.180
Why?
Dependovirus
1
2010
69
0.180
Why?
Amyotrophic Lateral Sclerosis
1
2010
44
0.180
Why?
History, 20th Century
1
2011
245
0.180
Why?
Therapeutic Misconception
1
2009
3
0.180
Why?
Research
2
1996
185
0.180
Why?
Orphan Drug Production
1
2009
6
0.180
Why?
Intestinal Absorption
1
2009
63
0.180
Why?
Opportunistic Infections
1
1989
20
0.180
Why?
Academic Medical Centers
1
2010
94
0.180
Why?
Eye Diseases
1
2009
43
0.180
Why?
Drug Approval
1
2009
20
0.180
Why?
Neuromuscular Diseases
1
1989
54
0.170
Why?
Risk
2
2006
355
0.170
Why?
Oxycodone
1
2009
10
0.170
Why?
Comprehension
1
2009
26
0.170
Why?
Delayed-Action Preparations
1
2009
44
0.170
Why?
Probability
3
2003
306
0.170
Why?
Psychomotor Performance
3
1998
165
0.170
Why?
Cross-Over Studies
2
1996
119
0.170
Why?
Carotid Arteries
1
1990
106
0.170
Why?
Observer Variation
3
2002
146
0.170
Why?
Medical Records
1
2009
140
0.170
Why?
Forecasting
2
2005
188
0.170
Why?
Patient Participation
1
2009
74
0.170
Why?
Motor Skills Disorders
2
2004
7
0.160
Why?
Dystonia
1
2008
21
0.160
Why?
Causality
2
1996
43
0.160
Why?
Societies, Medical
1
2009
142
0.160
Why?
Age of Onset
3
1994
126
0.160
Why?
Herpes Zoster
1
2009
60
0.160
Why?
Ethics, Clinical
1
2008
13
0.160
Why?
Capsules
1
2007
5
0.160
Why?
Gelatin
1
2007
14
0.160
Why?
Biological Availability
1
2007
38
0.160
Why?
Back Pain
1
2007
20
0.160
Why?
Diagnosis, Differential
2
1995
889
0.160
Why?
Trinucleotide Repeat Expansion
1
2008
50
0.160
Why?
Sinusitis
1
2007
24
0.160
Why?
Pruritus
1
2007
19
0.160
Why?
Akathisia, Drug-Induced
1
2007
7
0.160
Why?
Educational Status
2
2000
182
0.150
Why?
Recognition (Psychology)
1
2007
13
0.150
Why?
Safe Sex
1
2007
6
0.150
Why?
Prospective Studies
6
1994
1696
0.150
Why?
Sample Size
2
2000
31
0.150
Why?
Oxepins
1
2006
1
0.150
Why?
Tumor Necrosis Factor-alpha
4
2002
694
0.150
Why?
Enzyme-Linked Immunosorbent Assay
1
2008
472
0.150
Why?
Population Growth
1
2006
7
0.150
Why?
Food-Drug Interactions
1
2006
2
0.150
Why?
Tyramine
1
2006
3
0.150
Why?
Drug Evaluation, Preclinical
1
2007
79
0.150
Why?
Population Density
1
2006
16
0.150
Why?
Pilot Projects
3
2000
446
0.150
Why?
Adolescent
4
1994
5044
0.150
Why?
Internationality
1
2006
28
0.150
Why?
Emotions
1
2007
91
0.140
Why?
Models, Animal
1
2007
140
0.140
Why?
Drug Information Services
1
1986
5
0.140
Why?
Rural Health
1
2006
29
0.140
Why?
Diagnostic Imaging
1
2007
86
0.140
Why?
Malnutrition
1
2005
4
0.140
Why?
Personal Autonomy
1
2006
49
0.140
Why?
Reference Values
2
2003
453
0.140
Why?
Melanoma
1
2007
132
0.130
Why?
Neurons
3
1991
1105
0.130
Why?
Cell Survival
1
2007
559
0.130
Why?
Metals
1
2005
57
0.130
Why?
Prognosis
4
1995
1078
0.130
Why?
Internal Medicine
1
1986
107
0.130
Why?
Radiopharmaceuticals
1
2005
49
0.130
Why?
Nonlinear Dynamics
1
2005
35
0.130
Why?
Electrocardiography
1
2010
746
0.130
Why?
Anti-Retroviral Agents
1
2004
22
0.130
Why?
Verbal Learning
2
2000
33
0.130
Why?
Physicians, Family
1
1986
116
0.120
Why?
Mortality
1
2005
91
0.120
Why?
Substantia Nigra
1
2005
76
0.120
Why?
Neurons, Afferent
1
2005
98
0.120
Why?
Diet
1
2006
212
0.120
Why?
Chi-Square Distribution
4
2002
347
0.120
Why?
Interpersonal Relations
1
2006
166
0.120
Why?
Immune System
1
2005
69
0.120
Why?
Blood Pressure
1
2006
468
0.120
Why?
Health Surveys
1
2005
234
0.120
Why?
Predictive Value of Tests
4
2001
609
0.120
Why?
Skin Neoplasms
1
2007
230
0.120
Why?
Young Adult
1
2008
1084
0.120
Why?
Regression Analysis
2
2000
539
0.120
Why?
Thiazoles
1
2004
93
0.120
Why?
Mass Screening
1
2006
270
0.120
Why?
Peripheral Nerves
2
1998
50
0.120
Why?
Neoplasms
1
2010
743
0.120
Why?
Butanes
1
2002
3
0.110
Why?
Nitrogen Oxides
1
2002
14
0.110
Why?
Risk Factors
6
2001
2331
0.110
Why?
Communication
1
2006
282
0.110
Why?
Tocopherols
1
2002
24
0.110
Why?
Disabled Persons
1
2002
63
0.110
Why?
Patient Selection
3
2002
223
0.100
Why?
Brain Tissue Transplantation
2
1996
23
0.100
Why?
Smoking
1
2006
423
0.100
Why?
Matrix Metalloproteinase 2
3
2004
37
0.100
Why?
Drug Resistance
2
2010
100
0.100
Why?
Cytokines
1
2004
575
0.100
Why?
Apoptosis
1
2007
855
0.100
Why?
beta 2-Microglobulin
1
2000
19
0.100
Why?
Models, Biological
1
2006
1029
0.100
Why?
Patient Satisfaction
1
2003
243
0.090
Why?
Anti-HIV Agents
2
1997
182
0.090
Why?
Chemokine CCL2
3
2004
128
0.090
Why?
Nitrophenols
1
2000
5
0.090
Why?
Th1 Cells
1
2000
70
0.090
Why?
Aging
1
2006
705
0.090
Why?
Administration, Cutaneous
1
2000
33
0.090
Why?
Electroencephalography
2
1990
180
0.090
Why?
Th2 Cells
1
2000
91
0.090
Why?
Respiration
1
2000
181
0.090
Why?
Interleukin-4
1
2000
160
0.090
Why?
Mental Recall
1
2000
60
0.090
Why?
Leucine
1
1999
108
0.090
Why?
Confidence Intervals
3
2002
164
0.090
Why?
Platelet Activating Factor
1
1999
40
0.090
Why?
Imidazoles
1
1999
67
0.090
Why?
Neuritis
1
1998
16
0.080
Why?
HIV
1
1999
83
0.080
Why?
Reproducibility of Results
4
1997
903
0.080
Why?
Genes, Dominant
1
1999
82
0.080
Why?
Interferon-gamma
1
2000
341
0.080
Why?
Questionnaires
3
2006
1061
0.080
Why?
Positron-Emission Tomography
2
2005
38
0.080
Why?
Psychiatric Status Rating Scales
3
1995
332
0.080
Why?
Immunoglobulins, Intravenous
1
1997
37
0.080
Why?
Vasculitis
1
1997
30
0.080
Why?
DNA
2
1994
862
0.070
Why?
Drug Evaluation
2
1992
99
0.070
Why?
Fetal Tissue Transplantation
1
1996
24
0.070
Why?
Atrophy
1
1996
67
0.070
Why?
Reaction Time
2
2006
205
0.070
Why?
Macrophage Colony-Stimulating Factor
2
2004
25
0.060
Why?
Drug Interactions
1
1995
186
0.060
Why?
Tomography, Emission-Computed, Single-Photon
2
2004
71
0.060
Why?
Basal Ganglia Diseases
2
2003
17
0.060
Why?
Hippocampus
1
1996
216
0.060
Why?
Psychometrics
3
1997
232
0.060
Why?
Creatine Kinase
1
1994
56
0.060
Why?
Electromyography
1
1994
175
0.060
Why?
Pentetic Acid
1
1993
37
0.060
Why?
Angiography, Digital Subtraction
1
1992
20
0.060
Why?
Organometallic Compounds
1
1993
70
0.050
Why?
Toxicity Tests, Chronic
1
2012
1
0.050
Why?
Toxicity Tests, Acute
1
2012
3
0.050
Why?
Gadolinium
1
1991
18
0.050
Why?
Treatment Failure
1
2012
131
0.050
Why?
Leukocyte Count
1
1992
162
0.050
Why?
Social Behavior
1
2012
81
0.050
Why?
Meninges
1
1991
21
0.050
Why?
Psychological Tests
1
1991
83
0.050
Why?
Parenteral Nutrition
1
1991
24
0.050
Why?
Dogs
1
2012
492
0.050
Why?
Spinal Cord Diseases
1
1991
13
0.050
Why?
Carotid Artery, Internal
1
1991
31
0.050
Why?
Putamen
1
2010
14
0.050
Why?
Amobarbital
1
2010
10
0.050
Why?
Drug Toxicity
1
2010
17
0.050
Why?
Dominance, Cerebral
1
2010
51
0.050
Why?
Algorithms
2
2003
543
0.050
Why?
Phenytoin
1
1990
19
0.050
Why?
Lorazepam
1
1990
16
0.050
Why?
Base Sequence
1
1994
1721
0.050
Why?
Spinal Cord
1
1991
168
0.050
Why?
Image Enhancement
1
1991
148
0.040
Why?
Medication Adherence
1
2009
22
0.040
Why?
Molecular Sequence Data
1
1994
2046
0.040
Why?
Texas
1
2009
32
0.040
Why?
Syndrome
1
1989
209
0.040
Why?
Feasibility Studies
1
2009
212
0.040
Why?
Virus Diseases
1
1989
73
0.040
Why?
CD4-Positive T-Lymphocytes
1
1992
298
0.040
Why?
Mice
1
2000
6206
0.040
Why?
Enzyme Inhibitors
1
2010
441
0.040
Why?
Demography
1
2008
103
0.040
Why?
Single-Blind Method
1
2008
121
0.040
Why?
Analgesics, Opioid
1
2009
99
0.040
Why?
Motivation
1
2009
162
0.040
Why?
Anger
1
2007
16
0.040
Why?
Facial Expression
1
2007
16
0.040
Why?
Social Perception
1
2007
29
0.040
Why?
Pattern Recognition, Visual
1
2007
39
0.040
Why?
Fear
1
2007
50
0.040
Why?
Acute Disease
1
2009
591
0.040
Why?
Morbidity
1
2007
73
0.040
Why?
Pergolide
1
2006
2
0.040
Why?
Bromocriptine
1
2006
8
0.040
Why?
Clinical Trials, Phase III as Topic
1
2006
10
0.040
Why?
Statistics as Topic
1
2007
189
0.040
Why?
Medical Futility
1
2006
9
0.040
Why?
Oregon
1
1986
21
0.040
Why?
Prodrugs
1
2006
21
0.030
Why?
Bayes Theorem
1
2006
39
0.030
Why?
International Cooperation
1
2006
71
0.030
Why?
Nutritional Status
1
2006
44
0.030
Why?
Health Knowledge, Attitudes, Practice
1
2009
296
0.030
Why?
DNA Mutational Analysis
1
2006
192
0.030
Why?
Photic Stimulation
1
2007
232
0.030
Why?
Tomography, X-Ray Computed
1
1990
785
0.030
Why?
Child
2
1995
4342
0.030
Why?
Meta-Analysis as Topic
1
2005
36
0.030
Why?
Tetrabenazine
1
2005
5
0.030
Why?
Fluorine Radioisotopes
1
2005
8
0.030
Why?
Dihydroxyphenylalanine
1
2005
22
0.030
Why?
Ganglia, Spinal
1
2005
44
0.030
Why?
Karnofsky Performance Status
1
2004
14
0.030
Why?
Videotape Recording
1
2005
54
0.030
Why?
Carbon Radioisotopes
1
2005
79
0.030
Why?
Receptors, Dopamine
1
2005
24
0.030
Why?
Fluorodeoxyglucose F18
1
2005
15
0.030
Why?
Life Tables
1
2004
38
0.030
Why?
Intelligence Tests
1
2004
44
0.030
Why?
Biotransformation
1
2005
115
0.030
Why?
Dopamine Plasma Membrane Transport Proteins
1
2004
34
0.030
Why?
Body Mass Index
1
2006
229
0.030
Why?
Iodine Radioisotopes
1
2005
104
0.030
Why?
Affect
1
2004
78
0.030
Why?
Depression
2
1995
442
0.030
Why?
Drug Combinations
1
2004
150
0.030
Why?
Drug Synergism
1
2004
163
0.030
Why?
Cocaine
1
2005
69
0.030
Why?
Models, Immunological
1
2004
62
0.030
Why?
New York
1
2009
1378
0.030
Why?
Membrane Transport Proteins
1
2004
70
0.030
Why?
Blood-Brain Barrier
1
2005
110
0.030
Why?
Stem Cell Transplantation
1
2005
115
0.030
Why?
Ocular Motility Disorders
1
2003
10
0.030
Why?
Age Factors
1
2006
1152
0.030
Why?
Cytoprotection
1
2002
40
0.030
Why?
Motor Skills
1
2002
45
0.030
Why?
Nerve Tissue Proteins
1
2004
319
0.030
Why?
Membrane Glycoproteins
1
2004
376
0.030
Why?
Patient Compliance
1
2002
177
0.030
Why?
Disability Evaluation
1
2000
129
0.020
Why?
Multivariate Analysis
1
2001
548
0.020
Why?
Body Weight
1
2000
337
0.020
Why?
Socioeconomic Factors
1
1999
425
0.020
Why?
Muscle Weakness
1
1997
39
0.020
Why?
Netherlands
1
1997
28
0.020
Why?
Factor Analysis, Statistical
1
1997
57
0.020
Why?
Cross-Cultural Comparison
1
1997
35
0.020
Why?
Ethics, Professional
1
1996
6
0.020
Why?
Drug Tolerance
1
1996
35
0.020
Why?
Bias (Epidemiology)
1
1996
43
0.020
Why?
Safety Management
1
1996
29
0.020
Why?
Nerve Regeneration
1
1996
43
0.020
Why?
Graft Survival
1
1996
151
0.020
Why?
Neuronal Plasticity
1
1996
99
0.020
Why?
Gadolinium DTPA
1
1993
52
0.010
Why?
AIDS-Related Opportunistic Infections
1
1993
64
0.010
Why?
Contrast Media
1
1993
269
0.010
Why?

Visualizations


Kieburtz's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department